Evidence map›Paper›PMID 41325019›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2026

Complex-specific HDAC1/2 regulation in the heart: insights from MiDAC disruption.

Weijia Luo, Jiang Chang

Abstract readEditorial
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Weijia LuoCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia, United States.
Jiang ChangCenter for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, Texas, United States.ORCID 0000-0003-3707-7557

Funding

Metabolic Resuscitation in Heart Failure.R01HL176015 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Jiang Chang · 2024 to 2026
$2.2M
Epigenetic signaling, pathological cardiac hypertrophy and Western dietR01HL148133 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI CHANG, JIANG · 2020 to 2023
$2.2M
Epigenomic signaling and heart failure.R01HL150124 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI CHANG, JIANG · 2020 to 2023
$2.1M
Novel Insights into the Mechanistic Role of Small Rho GTPase in Chronic Cardiac Fibrotic RemodelingR01HL176744 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Weijia Luo · 2025 to 2026
$1.0M
American Heart Association (AHA) 23TPA1142716HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL148133HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL150124HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL176015HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL176744NHLBI NIH HHS R01 HL148133NHLBI NIH HHS R01 HL150124NHLBI NIH HHS R01 HL176015NHLBI NIH HHS R01 HL176744
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HDACHDAC complexHDAC inhibitors

Identifiers

PMID41325019
PMCPMC12794387

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.